Invention Grant
- Patent Title: Compounds and pharmaceutical compositions thereof for the treatment of diseases
-
Application No.: US16768825Application Date: 2018-11-26
-
Publication No.: US11339166B2Publication Date: 2022-05-24
- Inventor: Luke Jonathan Alvey , Denis Maurice Annoot , Florence Marie-Emilie Bonnaterre , Denis Bucher , Béranger Duthion , Hélène Marie Jary , Christophe Peixoto , Taoues Temal-Laib , Amynata Tirera , Nicolas Desroy
- Applicant: Galapagos NV
- Applicant Address: BE Mechelen
- Assignee: Galapagos NV
- Current Assignee: Galapagos NV
- Current Assignee Address: BE Mechelen
- Agency: ArentFox Schiff LLP
- Priority: GB1720101 20171202,GB1817343 20181025
- International Application: PCT/EP2018/082537 WO 20181126
- International Announcement: WO2019/105886 WO 20190606
- Main IPC: C07D487/04
- IPC: C07D487/04 ; C07D401/04 ; C07D403/04 ; C07D403/14 ; C07D413/04 ; C07D471/04 ; C07D491/10 ; C07D495/10

Abstract:
The present invention discloses compounds according to Formula I: wherein R1, R2, R3a, R3b, X, Y1, Y2, Y3, and Z are as defined herein. The present invention relates to compounds, methods for their production, pharmaceutical compositions comprising the same, and methods of treatment using the same, for the prophylaxis and/or treatment of inflammatory diseases, autoinflammatory diseases, autoimmune diseases, proliferative diseases, fibrotic diseases, transplantation rejection, diseases involving impairment of cartilage turnover, congenital cartilage malformation, diseases involving impairment of bone turnover, diseases associated with hypersecretion of TNFα, interferons, IL-6, IL-12 and/or IL-23, respiratory diseases, endocrine and/or metabolic diseases, cardiovascular diseases, dermatological diseases, and/or abnormal angiogenesis associated diseases by administering the compound of the invention.
Public/Granted literature
- US20210101903A1 NOVEL COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS THEREOF FOR THE TREATMENT OF DISEASES Public/Granted day:2021-04-08
Information query